Bullboard - Stock Discussion Forum Theriva Biologics Inc TOVX

Healthcare Biotechnology

Theriva Biologics, Inc. is a diversified clinical-stage company developing therapeutics designed to treat cancer and related diseases in areas of high unmet need. It is advancing a new oncolytic adenovirus platform. Its candidates are VCN-01, SYN-004 (ribaxamase) and SYN-020. VCN-01 is an oncolytic adenovirus designed to replicate selectively and aggressively within tumor cells, and to degrade... see more

Add To Watchlist

NYSEAM:TOVX - Post Discussion

Theriva Biologics Inc > TOVX.....early a.m runner on NR...set up for P.O ; )

View:

Post by Iseneschal on Oct 03, 2024 9:02am

TOVX.....early a.m runner on NR...set up for P.O ; )

Theriva™ Biologics Announces Positive Outcome of Data and Safety Monitoring Committee (DSMC) Review in Phase 1b/2a Clinical Trial of SYN-004 (ribaxamase) in Allogeneic Hematopoietic Cell Transplant Recipients

2024-10-03 05:00 ET - News Release

Here is the EDGAR filing for the P.O..... Make note: Pre-funded warrants will be dumped on the opening bell ; )

sec.gov/Archives/edgar/data/894158/000110465924101897/tm2423565d2_s1a.htm